Tevogen Total Current Liabilities vs Other Current Assets Analysis
| TVGNW Stock | 0.06 0 5.66% |
Tevogen Bio financial indicator trend analysis is much more than just breaking down Tevogen Bio Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tevogen Bio Holdings is a good investment. Please check the relationship between Tevogen Bio Total Current Liabilities and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Total Current Liabilities vs Other Current Assets
Total Current Liabilities vs Other Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tevogen Bio Holdings Total Current Liabilities account and Other Current Assets. At this time, the significance of the direction appears to have pay attention.
The correlation between Tevogen Bio's Total Current Liabilities and Other Current Assets is -0.73. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Tevogen Bio Holdings, assuming nothing else is changed. The correlation between historical values of Tevogen Bio's Total Current Liabilities and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Tevogen Bio Holdings are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Total Current Liabilities i.e., Tevogen Bio's Total Current Liabilities and Other Current Assets go up and down completely randomly.
Correlation Coefficient | -0.73 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Total Current Liabilities
Total Current Liabilities is an item on Tevogen Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tevogen Bio Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most indicators from Tevogen Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tevogen Bio Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Tevogen Bio's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to about 10.2 K in 2024, whereas Selling General Administrative is likely to drop slightly above 1.8 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 9.4K | 230.8K | 265.4K | 278.7K | Total Operating Expenses | 4.6M | 953.1K | 2.3M | 2.1M |
Tevogen Bio fundamental ratios Correlations
Click cells to compare fundamentals
Tevogen Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.